Monday, August 3, 2026
RSS

Markets-and-Money

Lantheus and Curium Merger: Implications for the Biotech Sector

Curium's merger with Lantheus marks a pivotal moment for the radiopharmaceutical industry, reshaping the market landscape.

Marcus Rivera • August 3, 2026
Markets-and-Money

Sony's Record-Breaking Box Office: What It Means for Investors

Sony's 'Spider-Man: Brand New Day' sets a record with $360 million opening, signaling potential financial gains for inve…

Sarah Chen • Aug 3
Markets-and-Money

Visa's $2.4 Billion Acquisition: A Strategic Move Against AI-Driven Fraud

Visa's acquisition of BioCatch for $2.4 billion signals a strong shift towards enhancing fraud detection amid rising AI …

James McAllister • Aug 3
Markets-and-Money

Supernus and Indivior Merger: A New Era for CNS Biopharmaceuticals

Supernus and Indivior's merger creates a major player in the CNS market, impacting investors in the specialty pharma sec…

Marcus Rivera • Aug 3
Free Newsletter

Informed positions start with informed mornings.

Market-moving analysis and institutional-grade research, complimentary and delivered daily.

By subscribing, I agree to receive marketing emails and alerts. View our Privacy Policy. You may unsubscribe at any time.

More Stories
Markets-and-Money
Curium and Lantheus Merger: Implications for US Traders and Investors
James McAllister • Aug 3, 2026
Markets-and-Money
TMX Group's $2.3B Deal: Implications for U.S. and Canadian Equity Markets
James McAllister • Aug 2, 2026